Acquisition of Group B streptococcus colonization in preterm pregnancy
This prospective cohort study demonstrates that Group B streptococcus (GBS) screening performed at the time of antepartum hospital admission for preterm pregnancy complications has a negative predictive value of 91.5% for GBS colonization status at the time of preterm delivery, a result comparable to that of routine screening at term.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Every pregnancy carries a silent, invisible risk: a common bacterium that lives harmlessly in the intestines and vagina of many adults can, if passed to a newborn during birth, cause severe illness. This germ, known as group B streptococcus, is a leading cause of early infections in babies, leading to dangerous conditions like blood poisoning, pneumonia, and inflammation of the brain. To protect infants, doctors in the United States routinely check pregnant people for this bacteria late in pregnancy, usually between 36 and 38 weeks. If the test is positive, the mother receives antibiotics during labor to stop the bacteria from reaching the baby. This system works well for full-term pregnancies because the timing is close to delivery, and the bacteria's presence is relatively stable. However, the rules become much murkier when a pregnancy ends early. Babies born prematurely are far more vulnerable to this infection, yet the standard screening window often misses them entirely because these births happen before the usual 36-week checkup.
This uncertainty creates a difficult dilemma for doctors managing high-risk pregnancies. When a patient is admitted to the hospital early due to complications like preterm labor or high blood pressure, she often has no recent test result to guide treatment. The standard advice is to test her immediately upon admission and, if the result is negative, to assume she remains negative for the next five weeks. This five-week window is a long time in the world of pregnancy, and the bacteria are known to be fickle, appearing and disappearing on their own. The critical question is whether a negative test taken weeks before a preterm birth is actually reliable, or if a mother could acquire the bacteria in the interim, leaving her baby unprotected.
A team of researchers at a major hospital in Ohio set out to answer this question by watching what actually happens in these high-stakes situations. They followed a group of 100 pregnant patients who were admitted to the hospital between 22 and 35 weeks of pregnancy. These were not routine checkups; these were women facing real medical complications that threatened to deliver their babies early. Upon admission, every woman was tested for the bacteria. Then, as the pregnancy progressed toward delivery, the researchers tested them again right before the baby was born. The goal was simple: to see if the first test accurately predicted the second. If the first test said "no bacteria" but the second test found them, the initial test had failed to protect the baby.
The results offered a reassuring, though not perfect, picture. In this group of women, the bacteria were found in 18 percent of the patients when they first arrived at the hospital, and in 20 percent when they delivered. This small increase suggests that some women did pick up the bacteria while they were waiting in the hospital. More importantly, the researchers calculated how well the initial test predicted the final status. They found that when the first test came back negative, it was correct 91.5 percent of the time. In other words, for every 100 women who tested negative at admission, about 92 of them remained negative at delivery, while about 8 acquired the bacteria in the meantime.
This finding challenges the idea that early screening is useless for preterm births. The study showed that the reliability of a negative test at admission is comparable to the reliability of the standard test done at full term. While there were seven cases where a woman tested negative at admission but positive at delivery, the overall accuracy remained high enough to support current medical practices. The researchers concluded that the increased risk of infection in premature babies is likely due to the babies' own biological fragility rather than a failure of the screening system to predict the mother's status. The study did not prove that the five-week rule is perfect, but it provided concrete evidence that a negative test at admission is a strong indicator of safety, giving doctors a solid foundation for their decisions when time is running out.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.